Aflibercept biosimilar

Product Name：Aflibercept biosimilar

CAS No.:  862111-32-8                                

Formula:   C₄₃₁₈H₆₇₈₈N₁₁₆₄O₁₃₀₄S₃₂                          

Molecular Weight：  115 kDa                  

Type:    a recombinant fusion protein                     

Target： VEGF
Antibody Form:  Purified immunoglobulin
Physical Form:  Solution
Storage:  -70±15℃ for long-term storage, 2-8℃ for short-term storage, away from light.

Aflibercept biosimilar is a recombinant fusion protein consisting of portions of human VEGF receptors 1 and 2 extracellular domains fused to the Fc portion of human IgG1 formulated as an iso-osmotic solution for intravitreal administration. Aflibercept biosimilar is a dimeric glycoprotein with a protein molecular weight of 97 kilodaltons (kDa) and contains glycosylation, constituting an additional 15% of the total molecular mass, resulting in a total molecular weight of 115 kDa. Aflibercept biosimilar is produced in recombinant Chinese hamster ovary (CHO) cells. 

For research use only.Not for use in humans